Sequences

Sample result

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

SIINFEKL, an exact peptide

Exact text → Patent proteins

Download as Excel

Every list and the search record, one sheet each.

Query
SIINFEKL · 8 lettersSIINFEKL
Set
Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran
2026-11-12
Found
771 sequences, 2,028 publications, 1,357 families

Charts

Identity against coverage

771 hits by identity and query coverage. 771 with a date.

Has a date90909292949496969898100100Identity (%)Query coverage (%)
Show table
Hits by identity
BandHas a dateAll
100%771771
Hits by query coverage
BandHas a dateAll
100%771771

Hits by year

1,357 families by year of first publication, 1994 to 2026.

Has a dateFamilies05010015019941997200020032006200920122015201820212024
Show table
Families by year of first publication
YearHas a dateAll
199411
199511
199855
199944
200022
20012323
20021414
20031717
20041515
20053737
20063131
20072929
20082828
20093232
20103232
20114848
20123535
20134646
20144242
20156161
20166969
20177979
20188282
20198686
20208080
20218787
20226666
20239494
2024102102
20258181
20262828

Where hits align on the query

The top 20 hits on SIINFEKL, a query of 8 amino acids: 20 cover the whole query, none differs from it.

Aligned partDiffers from the querySIINFEKL · 8 amino acids12468SIINFEKLAAE13361.1AAA94863.1AAC86077.1AAO94511.1AAO94501.1CS072231.1CS072222.1AZK27020.1CS072221.1ABH87918.1ABH87917.1ABH87919.1AX288232.1AX288234.1AX288233.1AX288231.1AX288237.1AX288235.1AX288236.1AQN09305.1
Show table
The top 20 hits on SIINFEKL, positions on the query
HitQuery fromQuery toIdentityDiffers atGaps atX at
AAE13361.118100.0%NoneNoneNone
AAA94863.118100.0%NoneNoneNone
AAC86077.118100.0%NoneNoneNone
AAO94511.118100.0%NoneNoneNone
AAO94501.118100.0%NoneNoneNone
CS072231.118100.0%NoneNoneNone
CS072222.118100.0%NoneNoneNone
AZK27020.118100.0%NoneNoneNone
CS072221.118100.0%NoneNoneNone
ABH87918.118100.0%NoneNoneNone
ABH87917.118100.0%NoneNoneNone
ABH87919.118100.0%NoneNoneNone
AX288232.118100.0%NoneNoneNone
AX288234.118100.0%NoneNoneNone
AX288233.118100.0%NoneNoneNone
AX288231.118100.0%NoneNoneNone
AX288237.118100.0%NoneNoneNone
AX288235.118100.0%NoneNoneNone
AX288236.118100.0%NoneNoneNone
AQN09305.118100.0%NoneNoneNone

Patents 2K

Columns
Tick the columns each row shows, then choose Show. The arrows move a column.

2,028 publications in 1,357 families match these filters.

  1. US 8628779-B22014-01-14

    Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof

    Institut Pasteur, Genticel, Institut National de la Sante et de la Recherche Medicale and Centre National de la Recherche Scientifique

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  2. US 8637028-B22014-01-28

    Adjuvant incorporation in immunonanotherapeutics

    President and Fellows of Harvard College, Massachusetts Institute of Technology and The Brigham and Women's Hospital

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  3. US 8637039-B22014-01-28

    Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof

    Institut Pasteur, Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique and Genticel

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  4. US 8637053-B22014-01-28

    Chlamydia antigens

    President and Fellows of Harvard College

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  5. WO 2014024965-A2014-02-13

    Antigen peptides derived from the T790M mutation of EGFR

    Kurume University

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  6. US 8658767-B22014-02-25

    Lipidated polyepitope vaccines

    National Health Research Institutes

    Best alignment

    Query 1 to 8, hit 74 to 81. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   74 SIINFEKL 81
    

    8 of 8 identical, no gaps.

  7. EP 2700708-A22014-02-26

    Enhancing the T-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and its use in vaccination

    UNIV BRUXELLES

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  8. JP 2014504851-A2014-02-27

    METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE TO EGFRVIII

    ADURO BIOTECH INC, PROVIDENCE HEALTH AND SERVICES - OREGON D/B/A PROVIDENCE PORTLAND MEDICAL CENTER

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  9. METHODS OF IMPROVING VACCINE IMMUNOGENICITY

    University of Iowa Research Foundation

    Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  10. CELL PENETRATING PEPTIDES

    UNIV GENEVE

    Best alignment

    Query 1 to 8, hit 35 to 42. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   35 SIINFEKL 42
    

    8 of 8 identical, no gaps.

  11. US 8685416-B22014-04-01

    Compositions and methods for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  12. US 8691210-B22014-04-08

    Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  13. US 8697093-B22014-04-15

    Vaccine composition based on sticholysin encapsulated into liposomes

    Centro De Immunologia Molecular

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  14. SYNTHETIC NANOCARRIERS THAT GENERATE HUMORAL AND CYTOTOXIC T LYMPHOCYTE (CTL) IMMUNE RESPONSES

    SELECTA BIOSCIENCES, INC

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  15. JP 2014510721-A2014-05-01

    METHODS FOR ENHANCING IMMUNOGEN SPECIFIC IMMUNE RESPONSES BY VECTORED VACCINES

    Immune Design Corp

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  16. COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNOTHERAPY

    US HEALTH

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  17. JP 2014513072-A2014-05-29

    Compositions and uses thereof

    Antonello Pessi

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  18. JP 2014513092-A2014-05-29

    TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS

    Selecta Biosciences Inc,Christopher Fraser,Takashi Kishimoto, Roberto Maldonado

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  19. US 8741810-B22014-06-03

    In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells

    University of Rochester

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  20. US 8742088-B22014-06-03

    Nucleic acids encoding antibodies or portions thereof comprising a heterologous T cell epitope and their use in modulating T cell responses

    Scancell Limited

    Best alignment

    Query 1 to 8, hit 75 to 82. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   75 SIINFEKL 82
    

    8 of 8 identical, no gaps.

  21. US 8772049-B22014-07-08

    Screening assays and methods

    President and Fellows of Harvard College

    Family of 5

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  22. JP 2014517828-A2014-07-24

    TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES

    Selecta Biosciences Inc,Christopher Fraser,Takashi Kishimoto, Roberto Maldonado

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  23. VACCINE COMPOSITION

    Nitto Denko Corporation

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  24. WO 2014123231-A2014-08-14

    Methods for identifying antigens of T cell receptor and reporter cells for the same

    University of Toyama

    Best alignment

    Query 1 to 8, hit 2 to 9. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   2 SIINFEKL 9
    

    8 of 8 identical, no gaps.

  25. US 8808692-B22014-08-19

    Compositions comprising immunoreactive reagents and saponins, and methods of use thereof

    CSL Limited

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  26. US 8809259-B22014-08-19

    Charged nutritive proteins and methods

    Pronutria, Inc.

    Family of 5

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  27. US 8809290-B22014-08-19

    Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells

    Multicell Immunotherapeutics, Inc.

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  28. EP 2770061-A12014-08-27

    Non-integrating lentiviral vectors

    IMMUNE DESIGN CORP

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  29. JP 2014521687-A2014-08-28

    Synthetic Nanocarriers that Generate Humoral and Cytotoxic T Lymphocyte (CTL) Immune Responses

    Selecta Biosciences Inc,David Altreuter,Conlin O'Neil,Petr Ilyinskii

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  30. VACCINATION STRATEGY

    UNIV BONN

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  31. JP 2014523406-A2014-09-11

    INDIVIDUALIZED VACCINES FOR CANCER

    BioNTech AG, TRON -TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, WO2011EP2576.

  32. JP 2014169281-A2014-09-18

    VACCINE COMPOSITION

    NITTO DENKO CORPORATION

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  33. US 8852612-B22014-10-07

    Universal carrier for targeting molecules to Gb3 receptor expressing cells

    Institute Curie, Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale and Universite Pierre et Marie Curie (Paris VI)

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

  34. US 8871221-B22014-10-28

    Methods of stimulating protective immunity employing Dengue viral antigens

    Vaxinnate Corporation

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 765 to 772. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   765 SIINFEKL 772
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  35. EP 2796423-A12014-10-29

    Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

    CORNING INC

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  36. Dual Antigen-Induced Bipartite Functional Complementation

    JULIUS-MAXIMILIANS UNIVERSITAET WUERZBURG

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  37. US 8883171-B22014-11-11

    Computationally optimized broadly reactive antigens for influenza

    University of Pittsburgh-Of the Commonwealth System of Higher Education

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  38. JP 2014531427-A2014-11-27

    Nanoparticle Tumour Vaccines

    MIDATECH LIMITED,IMMUNOTOPE INC

    Best alignment

    Query 1 to 8, hit 3 to 10. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    3 SIINFEKL 10
    

    8 of 8 identical, no gaps.

  39. EP 2807193-A12014-12-03

    COMPOSITIONS AND METHODS OF MODULATING AN IMMUNE RESPONSE

    BIOMMUNE TECHNOLOGIES INC

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  40. US 8906359-B22014-12-09

    Recombinant retrovirus pseudotyped with a E2 alphavirus glycoprotein

    California Institute of Technology

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  41. US 8911722-B22014-12-16

    Modulation of yeast-based immunotherapy products and responses

    The Regents of the University of Colorado, a body corporate

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  42. US 8916172-B22014-12-23

    MVA expressing modified HIV envelope, gag, and pol genes

    Emory University, National Institute of Allergy and Infectious Diseases (NIAID) and The United States of America, as represented by the Department of Health and Human Services

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  43. US 8926993-B22015-01-06

    Methods and compositions using Listeria for enhancing immunogenicity by prime boost

    Aduro Biotech

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  44. WO 2015002134-A2015-01-08

    Vaccine that induces cell-mediated immunity

    Japanese Foundation for Cancer Research,The Jikei University

    Best alignment

    Query 1 to 8, hit 157 to 164. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   157 SIINFEKL 164
    

    8 of 8 identical, no gaps.

  45. EP 2825693-A12015-01-21

    METHODS AND MATERIALS FOR TREATING CANCER

    MAYO FOUNDATION

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  46. ENHANCED AFFINITY T CELL RECEPTORS AND METHODS FOR MAKING THE SAME

    FRED HUTCHINSON CANCER RESEARCH CENTER

    Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  47. ERYTHROCYTE-BINDING THERAPEUTICS

    ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)

    Family of 6

    Best alignment and family

    Query 1 to 8, hit 8 to 15. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    8 SIINFEKL 15
    

    8 of 8 identical, no gaps.

    Family of 6

    Grouped by the same title and applicant. No priority claim is on record.

  48. US 8945579-B22015-02-03

    Methods of treatment with compositions that include hemagglutinin

    VaxInnate Corporation

    Best alignment

    Query 1 to 8, hit 765 to 772. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   765 SIINFEKL 772
    

    8 of 8 identical, no gaps.

  49. US 8945591-B22015-02-03

    Methods and compositions involving immunostimulatory oligodeoxynucleotides

    Valneva Austria GmbH

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  50. EP 2831097-A12015-02-04

    NUTRITIVE FRAGMENTS AND PROTEINS WITH LOW OR NO PHENYLALANINE AND METHODS

    PRONUTRIA INC

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.